Julien Mazières1, Jean-Louis Pujol, Nikos Kalampalikis, Diane Bouvry, Elisabeth Quoix, Thomas Filleron, Nathalie Targowla, Denise Jodelet, Julie Milia, Bernard Milleron. 1. *Thoracic Oncology Department, Larrey Hospital, University Hospital of Toulouse, University of Toulouse III (Paul Sabatier), Toulouse, France; †Thoracic Oncology Unit; and ‡Epsylon Laboratory, Montpellier Academic Hospital, Montpellier, France; §Social Psychology Research Group (EA 4163), University Lyon 2, France; ‖Pulmonary Department, Avicenne Hospital, Bobigny, France; ¶Pulmonary Department, University Hospital of Strasbourg, France; #Statistic Department, Institut Universitaire du Cancer, Toulouse, France; **General Practitioner Clinic, Levallois Perret, France; ††Interdisciplinary Institute for Contemporary Anthropology, UMR 8177 CNRS/EHESS, Ehess, France; ‡‡Hopital Tenon APHP, Paris, France; and §§Intergroupe Francophone de Cancérologie Thoracique, Paris, France.
Abstract
INTRODUCTION: To evaluate the perception of lung cancer in the general population to identify obstacles in patient-doctor communications. METHODS: A prospective nationwide survey was conducted using a questionnaire and lexical approaches given to 2200 healthy subjects selected within a representative polling database. RESULTS: Of the 1469 subjects eligible for full analysis, most were well informed regarding the epidemiological changes to lung cancer and the main risk factors. The overall survival of patients with lung cancer (32%) was overestimated, and the survival of patients with early stages of lung cancer was underestimated (52%). Lung cancer was identified as a severe disease (82%) with a worse prognosis than other cancers. Most of the population was aware of the main treatments available, except for targeted therapy. Using lexical analyses, we observed that a major proportion considered lung cancer to be a tobacco-induced, life-threatening disease that involved major treatment, and a minor proportion considered it to be an environmentally induced disease. Compared with breast cancer, lung cancer was characterized by a greater feeling of guilt and was more frequently associated with lifestyle. CONCLUSIONS: We have identified knowledge gaps in the perception of lung cancer and have highlighted a need for a public information campaign on lung-cancer screening to promote the good survival rate from early-stage disease and the progress achieved with new therapeutic strategies.
INTRODUCTION: To evaluate the perception of lung cancer in the general population to identify obstacles in patient-doctor communications. METHODS: A prospective nationwide survey was conducted using a questionnaire and lexical approaches given to 2200 healthy subjects selected within a representative polling database. RESULTS: Of the 1469 subjects eligible for full analysis, most were well informed regarding the epidemiological changes to lung cancer and the main risk factors. The overall survival of patients with lung cancer (32%) was overestimated, and the survival of patients with early stages of lung cancer was underestimated (52%). Lung cancer was identified as a severe disease (82%) with a worse prognosis than other cancers. Most of the population was aware of the main treatments available, except for targeted therapy. Using lexical analyses, we observed that a major proportion considered lung cancer to be a tobacco-induced, life-threatening disease that involved major treatment, and a minor proportion considered it to be an environmentally induced disease. Compared with breast cancer, lung cancer was characterized by a greater feeling of guilt and was more frequently associated with lifestyle. CONCLUSIONS: We have identified knowledge gaps in the perception of lung cancer and have highlighted a need for a public information campaign on lung-cancer screening to promote the good survival rate from early-stage disease and the progress achieved with new therapeutic strategies.
Authors: Suzanne Wait; Arturo Alvarez-Rosete; Tasnime Osama; Dani Bancroft; Robin Cornelissen; Ante Marušić; Pilar Garrido; Mariusz Adamek; Jan van Meerbeeck; Annemiek Snoeckx; Olivier Leleu; Ebba Hallersjö Hult; Sébastien Couraud; David R Baldwin Journal: JTO Clin Res Rep Date: 2022-04-22
Authors: Nicole El-Turk; Michael S H Chou; Natasha C H Ting; Afaf Girgis; Shalini K Vinod; Victoria Bray; Claudia C Dobler Journal: PLoS One Date: 2021-01-22 Impact factor: 3.240
Authors: Samantha L Quaife; Charlotte Vrinten; Mamta Ruparel; Samuel M Janes; Rebecca J Beeken; Jo Waller; Andy McEwen Journal: BMC Cancer Date: 2018-05-02 Impact factor: 4.430